Mattes Glenn R.
- SEC CIK
- 0001568678
No open-market purchases or sales filed in the past year.
Current role at each company
- TFFP TFF Pharmaceuticals, Inc.President and CEOas of May 17, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mattes Glenn R. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 17, 2022 (view filing) | May 16 | 1 day | Mattes Glenn R.President and CEO | PPurchase | +16.0K | $4.78 | +$76.5K | +80.0%36.0K after | |
| Sep 16, 2021 (view filing) | Sep 16 | Same day | Mattes Glenn R.President and CEO | PPurchase | +10.0K | $7.10 | +$71.0K | +100.0%20.0K after |